These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats. Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217 [TBL] [Abstract][Full Text] [Related]
4. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models. Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527 [TBL] [Abstract][Full Text] [Related]
5. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents. Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636 [TBL] [Abstract][Full Text] [Related]
6. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats. Roth JD; Hughes H; Coffey T; Maier H; Trevaskis JL; Anderson CM Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1112-7. PubMed ID: 17698985 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity. Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760 [TBL] [Abstract][Full Text] [Related]
8. Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats. Boozer CN; Leibel RL; Love RJ; Cha MC; Aronne LJ Metabolism; 2001 Aug; 50(8):889-93. PubMed ID: 11474475 [TBL] [Abstract][Full Text] [Related]
9. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine. Mashiko S; Ishihara A; Iwaasa H; Moriya R; Kitazawa H; Mitobe Y; Ito J; Gomori A; Matsushita H; Takahashi T; MacNeil DJ; Van der Ploeg LH; Fukami T; Kanatani A Obesity (Silver Spring); 2008 Jul; 16(7):1510-5. PubMed ID: 18421274 [TBL] [Abstract][Full Text] [Related]
10. Regulation of body weight and carcass composition by sibutramine in rats. Strack AM; Shu J; Camacho R; Gorski JN; Murphy B; MacIntyre DE; Hickey GJ Obes Res; 2002 Mar; 10(3):173-81. PubMed ID: 11886940 [TBL] [Abstract][Full Text] [Related]
11. Effects of oleoyl-estrone with dexfenfluramine, sibutramine or phentermine on overweight rats. Ferrer-Lorente R; Cabot C; Fernández-López JA; Remesar X; Alemany M Eur J Pharmacol; 2005 Apr; 513(3):243-8. PubMed ID: 15862807 [TBL] [Abstract][Full Text] [Related]
12. Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin. Boyle CN; Rossier MM; Lutz TA Physiol Behav; 2011 Jul; 104(1):20-8. PubMed ID: 21550355 [TBL] [Abstract][Full Text] [Related]
13. Chronic intracerebroventricular administration of recombinant CART(42-89) peptide inhibits and causes weight loss in lean and obese Zucker (fa/fa) rats. Larsen PJ; Vrang N; Petersen PC; Kristensen P Obes Res; 2000 Nov; 8(8):590-6. PubMed ID: 11156435 [TBL] [Abstract][Full Text] [Related]
14. S 23521 decreases food intake and body weight gain in diet-induced obese rats. Claret M; Corominola H; Canals I; Nadal B; Chavanieu A; Pfeiffer B; Renard P; Gorostiaga C; Delagrange P; Grassy G; Gomis R Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223 [TBL] [Abstract][Full Text] [Related]
15. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527 [TBL] [Abstract][Full Text] [Related]
16. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. Roth JD; Hughes H; Kendall E; Baron AD; Anderson CM Endocrinology; 2006 Dec; 147(12):5855-64. PubMed ID: 16935845 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of sibutramine and other weight-modifying drugs on extracellular dopamine in the nucleus accumbens of freely moving rats. Rowley HL; Butler SA; Prow MR; Dykes SG; Aspley S; Kilpatrick IC; Heal DJ Synapse; 2000 Nov; 38(2):167-76. PubMed ID: 11018791 [TBL] [Abstract][Full Text] [Related]
19. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice. Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759 [TBL] [Abstract][Full Text] [Related]
20. A selective cannabinoid-1 receptor antagonist, PF-95453, reduces body weight and body fat to a greater extent than pair-fed controls in obese monkeys. Wagner JD; Zhang L; Kavanagh K; Ward GM; Chin JE; Hadcock JR; Auerbach BJ; Harwood HJ J Pharmacol Exp Ther; 2010 Oct; 335(1):103-13. PubMed ID: 20605903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]